Search results
Found 2 matches for
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
Oxfordshire-based SCAN pathway wins BMJ award
Innovation Research
9 October 2020
A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.
10-Year Partnership with Genesis Care
Clinical Trials Innovation Research
7 February 2019
GenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer.